Biogen shares soar as FDA reviewers support Alzheimer’s drug
AUCKLAND: Biogen’s experimental Alzheimer’s disease therapy appears effective despite conflicting clinical-trial results, according to a…
AUCKLAND: Biogen’s experimental Alzheimer’s disease therapy appears effective despite conflicting clinical-trial results, according to a…